Related Experiment Videos
[Adjuvant chemotherapy of osteosarcoma].
1Dept of Orthop, National Sapporo Hospital Hokkaido Cancer Center.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|February 1, 1990
Summary
Chemotherapy significantly improves outcomes for osteosarcoma patients, enhancing survival rates and enabling limb-sparing surgery. This treatment approach is crucial for managing this bone cancer effectively.
Area of Science:
- Oncology
- Orthopedic Oncology
- Surgical Oncology
Background:
- Osteosarcoma treatment has evolved significantly with the integration of chemotherapy.
- Key chemotherapeutic agents include adriamycin, high-dose methotrexate with Leucovorin rescue, and cisplatinum.
- Current treatment goals focus on patient survival and limb function preservation.
Observation:
- Preoperative chemotherapy for limb salvage is increasingly utilized in extremity osteosarcoma.
- This approach has led to a five-year survival rate of 65%.
- Limb-sparing surgery rates have exceeded 50% with this strategy.
Findings:
- Preoperative and postoperative chemotherapy regimens are effective in managing osteosarcoma.
- These chemotherapy protocols demonstrate efficacy in inhibiting pulmonary micrometastasis.
- Combined chemotherapy and limb-sparing surgery significantly improve patient survival rates.
Implications:
- The current chemotherapy protocols are vital for improving survival in osteosarcoma patients.
- Limb salvage operations are achievable in a significant number of patients.
- Multimodal treatment strategies are essential for optimizing outcomes in osteosarcoma management.